Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
Coagulation01:09

Coagulation

9.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.5K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

6.4K
Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.4K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

1.6K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.6K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

14.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Foetal haemoglobin, erythrocytes containing foetal haemoglobin, and hematological features in congolese patients with sickle cell anaemia.

Anemia·2012
Same author

[The problem of sickle cell disease in Africa].

Medecine tropicale : revue du Corps de sante colonial·2011
Same author

[Pathophysiology of sickle cell disease].

Medecine tropicale : revue du Corps de sante colonial·2011
Same author

Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3.

European journal of medical genetics·2009
Same author

[Effect of hydroxyurea on adhesion proteins in sickle cell anemia].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2009
Same author

Neonatal screening for sickle cell disease in France.

Journal of clinical pathology·2008
Same journal

Conditional Knockout of Indoleamine 2, 3-Dioxygenase-1 in Osteoprogenitor Cells in Mice Results in Sex-dependent Differences in Bone Mass.

Biochimie·2026
Same journal

Sedentariness disrupts, while exercise restores, thermogenic and metabolic plasticity in inguinal adipose tissue of mice.

Biochimie·2026
Same journal

Chrononutrition as a modulator of retinal metabolic resilience: A translational framework linking circadian biology to ocular disease.

Biochimie·2026
Same journal

Heterologous Expression, Purification, and Biophysical Characterisation of the Cobalt-Dependent Nitrile Hydratase from Rhodococcus rhodochrous ATCC BAA-870.

Biochimie·2026
Same journal

The Impact of microplastics and nanoplastics on human health: a growing concern.

Biochimie·2026
Same journal

Iron-acquisition-targeted therapy for multidrug-resistant Klebsiella pneumoniae: siderophore-antibiotic conjugates, clinical evidence, and emerging resistance.

Biochimie·2026
See all related articles

Related Experiment Video

Updated: Jan 8, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

973

Ca++ binding properties of human prothrombin

R Benarous, J Elion, D Labie

    Biochimie
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Human prothrombin binds calcium ions (Ca++) with positive cooperativity, revealing distinct strong and weak binding sites. This calcium binding is crucial for prothrombin

    More Related Videos

    Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
    07:13

    Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

    Published on: May 24, 2024

    900
    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
    13:08

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

    Published on: September 9, 2012

    19.3K

    Related Experiment Videos

    Last Updated: Jan 8, 2026

    Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
    04:37

    Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

    Published on: May 23, 2025

    973
    Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
    07:13

    Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

    Published on: May 24, 2024

    900
    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
    13:08

    Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

    Published on: September 9, 2012

    19.3K

    Area of Science:

    • Biochemistry
    • Protein-ligand interactions
    • Calcium signaling

    Background:

    • Prothrombin is a key protein in the blood coagulation cascade.
    • Calcium ions are essential cofactors for many biological processes, including hemostasis.
    • Understanding calcium binding to prothrombin is vital for comprehending coagulation regulation.

    Purpose of the Study:

    • To investigate the quantitative aspects of calcium ion (Ca++) binding to human prothrombin.
    • To characterize the binding sites and cooperativity of Ca++ interaction with human prothrombin.
    • To compare Ca++ binding characteristics between human and bovine prothrombin.

    Main Methods:

    • Equilibrium dialysis was employed to measure Ca++ binding to human prothrombin.
    • Analysis of binding data allowed for the determination of binding site numbers and affinities.
    • The Hill coefficient was assessed to quantify cooperativity in Ca++ binding.

    Main Results:

    • Human prothrombin exhibits positive cooperativity for the initial Ca++ binding events.
    • A total of 11-12 Ca++ binding sites were identified.
    • Two classes of binding sites were resolved: 5 strong sites (log Kassoc = 3.9) and 7 weak sites (log Kassoc = 2.9).

    Conclusions:

    • Human prothrombin possesses distinct high- and low-affinity calcium binding sites.
    • The observed cooperativity in Ca++ binding is attributed to specific strong binding sites.
    • These findings provide insights into the role of calcium in modulating human prothrombin function and its comparison to bovine prothrombin.